New India-based Initiative to Oppose Patenting of HIV Medications
14 Sep 2006
A recently-launched project--the Initiative for Medicines, Access & Knowledge (I-MAK)--has established among its goals an endeavor to oppose the patenting of HIV medications in India.
The I-MAK project presently is in a state of development, and its Web site, http://www.i-mak.org/, currently is under construction. However, the India-based Initiative states that it intends to address the broader issue of the relationship between intellectual property laws and patients' access to critical medicines. In addition to its objective of opposing the patenting of HIV medications in India, the Initiative will concentrate broadly on preventing patents for critical medicines from being granted in cases where the patentability of those medicines is "questionable."
Thus far, I-MAK has released the first of its Pat(i)entWatch newsletters, available online at http://www.i-mak.org/patientwatch.pdf.
Source: I-MAK: Initiative for Medicines, Access & Knowledge. [Online] www.i-mak.org.
Go to website
|
|
Related Categories
|
